Ameriprise’s Korro Bio KRRO Stock Holding History

Ameriprise’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-406	Closed	-$193K	–	3932
2021 Q1	$193K	Sell	406 -607	-60%	-$1.18M	﹤0.01%	3711
2020 Q4	$1.79M	Buy	+1,013	New	+$1.34M	﹤0.01%	2848

Other funds holding KRRO

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SDIC

South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LOAMS

Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return

Ameriprise's KRRO Position: Q2 2021 in Review

Ameriprise sold out of Korro Bio (KRRO) in Q2 2021, closing a stake of 406 shares — an estimated $193K sold.

Ameriprise first reported a position in KRRO in Q4 2020 and held it in 2 quarters. The position peaked at $1.79M in Q4 2020. 91 funds tracked by Wall St. Rank hold KRRO as of Q2 2021.

Ameriprise reported no remaining Korro Bio position as of Q2 2021 after selling out during the quarter.
Ameriprise sold 406 Korro Bio shares in Q2 2021, an estimated $193K.
Ameriprise first reported a position in Korro Bio in Q4 2020 and held it in 2 quarters.
Ameriprise's Korro Bio position peaked at $1.79M in Q4 2020.
91 funds tracked by Wall St. Rank held Korro Bio as of Q2 2021.

Based on Ameriprise's 13F filing for Q2 2021, filed 16 Aug 2021.